You will be redirected to the related website.
This information helps us optimize our content and make surfing on our site more convenient for you. In some cases, cookies are also used to make specific information about our products available on websites of other providers. This is why we also work with external service companies which use the information obtained from cookies exclusively for this purpose.
The information obtained from cookies is not used for any further purpose.
You can adjust the settings on your browser so that you are notified whenever a server wants to send you a cookie. You can accept or reject cookies; you can also completely block them. Further information is available in the help function of your browser.
In light of the discussion about the use of Analysetools and complete IP addresses, we wish to state that this website works with Google Analytics and the "_anonymizeIp()" function; consequently, it only processes partial IP addresses so as to rule out identifying information.
You can refuse the use of Google Analytics by clicking on the following link. An opt-out cookie will be set on the computer, which prevents the future collection of your data when visiting this website: Disable Google Analytics.*
Pelargonium sidoides, the plant that provides the active ingredients for EPs® 7630, originally comes from South Africa. Nevertheless, it is really something of a coincidence that the crude drug was ever discovered in Europe at all. In 1897, on the recommendation of his doctor, the Englishman C. H. Stevens travelled to South Africa hoping the climate would cure his tuberculosis.
After his recovery, Stevens returned to England taking with him roots of the South African pelargonium. Once home, he developed ’Stevens′ Consumption Cure’, which included the plant′s powdered root. He first sold it in England and then across Europe as a cure for tuberculosis.
With the arrival of more ’advanced’ modern medicines, Stevens′ remedy and therefore the plant were largely forgotten. It took several decades before this herbal drug found its way into European laboratories in the middle of the last century.
Schwabe Pharmaceuticals started its research on the plant Pelargonium sidoides and its pharmaceutical effects. The search for the botanical origin of the drug — i.e. the identification of the true mother plant — was as interesting as arduous. The application of modern chemical and analytical methods was successful in determining the identity of the plant. With the identification of the source plant, the foundation for undertaking scientific studies on a large scale had become established in modern European medicine.
Today, the special extract of Pelargonium sidoides root is marketed by Schwabe Pharmaceuticals in over 50 countries worldwide under various brand names such as Umckaloabo®, Umcka®, Umckalor®, Kaloba®, Kaloban® and Renikan®. Since its development, several different pharmaceutical forms have become available such as solutions, tablets and syrups. Special extract EPs® 7630 has been successfully used by millions to treat a wide range of respiratory tract infections.